MITEM

Swiss trademark · 663983 · Word mark · In force

Register entry

Registration number
663983
Application number
58356/2014
Status
In force
Type
Word mark
Filed
Jul 17, 2014
Registered
Sep 24, 2014
Published
Sep 24, 2014
Protected until
Jul 17, 2034
Language of procedure
French
Source
Swissreg

Goods and services

Pharmaceuticals

Arzneimittel zur Verwendung auf dem Gebiet der Onkologie.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 26, 2024

    Agent’s address changed

    Representative
    AWA SWITZERLAND SA, Rue de la Faïencerie 2, 1227 Carouge GE → AWA Switzerland SA, Rue de la Faïencerie 2, 1227 Carouge GE

    Published in Swissreg on 26.09.2024

  2. Jun 10, 2024

    Renewed

    Published in Swissreg on 10.06.2024

  3. Dec 29, 2023

    Agent removed

    Representative
    FMP Fuhrer Marbach & Partner, Konsumstrasse 16A, 3007 Bern (removed)

    Published in Swissreg on 29.12.2023

  4. Dec 29, 2023

    Transferred

    Owner
    VYGORIS LIMITED, 930 High Road, London, N12 9RT, United Kingdom → Substipharm, 24 Rue Erlanger, 75016 PARIS, France
    Representative
    AWA SWITZERLAND SA, Rue de la Faïencerie 2, 1227 Carouge GE

    Published in Swissreg on 29.12.2023

  5. Nov 2, 2017

    Transferred

    Owner
    Speciality European Pharma Limited, 16 John Street, WC1N 2DL London, United Kingdom → Substipharm Limited, 930 High Road, London, N12 9RT, United Kingdom

    Published in Swissreg on 02.11.2017

  6. Nov 2, 2017

    Holder’s address changed

    Owner
    Substipharm Limited, 930 High Road, London, N12 9RT, United Kingdom → VYGORIS LIMITED, 930 High Road, London, N12 9RT, United Kingdom

    Published in Swissreg on 02.11.2017

  7. Sep 24, 2014

    Registered

    Published in Swissreg on 24.09.2014

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.